D-Index & Metrics Best Publications
Immunology
Germany
2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 70 Citations 15,440 321 World Ranking 1581 National Ranking 100
Medicine D-index 73 Citations 17,477 358 World Ranking 15880 National Ranking 813

Research.com Recognitions

Awards & Achievements

2023 - Research.com Immunology in Germany Leader Award

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Immune system
  • Cancer

His main research concerns Immunology, Tuberculosis, Mycobacterium tuberculosis, Intensive care medicine and Immune system. His Immunology study integrates concerns from other disciplines, such as Cytotoxic T cell and Disease. His studies in Tuberculosis integrate themes in fields like Internal medicine, Clinical trial, Acquired immunodeficiency syndrome, Global health and Drug resistance.

Within one scientific family, he focuses on topics pertaining to Pandemic under Mycobacterium tuberculosis, and may sometimes address concerns connected to Public health. His Intensive care medicine research is multidisciplinary, incorporating perspectives in Bedaquiline, Drug development and Pharmacology. His Immune system research integrates issues from Infectious disease, Interleukin and Infiltration.

His most cited work include:

  • Antigen-processing machinery breakdown and tumor growth. (378 citations)
  • Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test (308 citations)
  • Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen. (242 citations)

What are the main themes of his work throughout his whole career to date?

Markus Maeurer mainly focuses on Immunology, Immune system, Tuberculosis, Antigen and Mycobacterium tuberculosis. His research investigates the connection with Immunology and areas like Virology which intersect with concerns in Immunoglobulin G. His work carried out in the field of Immune system brings together such families of science as Inflammation, Cancer and Cytokine.

Pharmacology is closely connected to Intensive care medicine in his research, which is encompassed under the umbrella topic of Tuberculosis. His research in Epitope intersects with topics in Molecular biology, Peptide microarray, CTL* and Major histocompatibility complex. His MHC class I research incorporates themes from Antigen presentation and MHC class II.

He most often published in these fields:

  • Immunology (65.84%)
  • Immune system (41.09%)
  • Tuberculosis (35.64%)

What were the highlights of his more recent work (between 2018-2021)?

  • Immunology (65.84%)
  • Immune system (41.09%)
  • Inflammation (5.20%)

In recent papers he was focusing on the following fields of study:

Markus Maeurer focuses on Immunology, Immune system, Inflammation, Disease and Antibody. His studies deal with areas such as Cancer and Coronavirus as well as Immunology. His Immune system research includes elements of Cytotoxic T cell, Cancer research and Antigen.

His research in the fields of Immunogenicity overlaps with other disciplines such as Gorilla. Markus Maeurer has included themes like Severe acute respiratory syndrome coronavirus 2, Adjuvant, BCG vaccine, Tuberculosis and Innate immune system in his Immunity study. His Tuberculosis research incorporates elements of Drug resistance, Coronavirus disease 2019 and 2019-20 coronavirus outbreak.

Between 2018 and 2021, his most popular works were:

  • Reducing mortality from 2019-nCoV: host-directed therapies should be an option. (199 citations)
  • Single-cell landscape of immunological responses in patients with COVID-19. (100 citations)
  • Immunological and inflammatory profiles in mild and severe cases of COVID-19. (80 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Immune system
  • Cancer

Markus Maeurer mainly investigates Immunology, Immune system, Inflammation, Disease and Coronavirus disease 2019. Immunology is closely attributed to Allele in his work. The study incorporates disciplines such as Cytotoxic T cell and Clinical trial in addition to Immune system.

Markus Maeurer has researched Disease in several fields, including Acquired immune system, Serology, Antibody, Asymptomatic and Monocyte. His research in Coronavirus disease 2019 tackles topics such as 2019-20 coronavirus outbreak which are related to areas like Coronavirus Infections, Viral therapy, Betacoronavirus and Intensive care medicine. Markus Maeurer works in the field of Tuberculosis, namely Mycobacterium tuberculosis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Antigen-processing machinery breakdown and tumor growth.

Barbara Seliger;Markus J Maeurer;Soldano Ferrone.
Immunology Today (2000)

591 Citations

Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test

Stephen D Lawn;Peter Mwaba;Peter Mwaba;Matthew Bates;Amy Piatek.
Lancet Infectious Diseases (2013)

559 Citations

Reducing mortality from 2019-nCoV: host-directed therapies should be an option.

Alimuddin Zumla;Alimuddin Zumla;David S Hui;Esam I Azhar;Ziad A Memish.
The Lancet (2020)

441 Citations

New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects

Alimuddin I Zumla;Alimuddin I Zumla;Stephen H Gillespie;Michael Hoelscher;Patrick P J Philips.
Lancet Infectious Diseases (2014)

382 Citations

Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

Markus J. Maeurer;Susanne M. Gollin;Dina Martin;William Swaney.
Journal of Clinical Investigation (1996)

378 Citations

Single-cell landscape of immunological responses in patients with COVID-19.

Ji Yuan Zhang;Xiang Ming Wang;Xudong Xing;Zhe Xu.
Nature Immunology (2020)

342 Citations

Drug-resistant tuberculosis: time for visionary political leadership

Ibrahim Abubakar;Ibrahim Abubakar;Matteo Zignol;Dennis Falzon;Mario Raviglione.
Lancet Infectious Diseases (2013)

335 Citations

TAP off — tumors on

Barbara Seliger;Barbara Seliger;Markus J. Maeurer;Markus J. Maeurer;Soldano Ferrone;Soldano Ferrone.
Immunology Today (1997)

305 Citations

Tuberculosis comorbidity with communicable and non-communicable diseases: integrating health services and control efforts

Ben J Marais;Knut Lönnroth;Stephen D Lawn;Stephen D Lawn;Giovanni Battistai Migliori.
Lancet Infectious Diseases (2013)

298 Citations

Diagnosing Helicobacter pylori in vivo by confocal laser endoscopy.

Ralf Kiesslich;Martin Goetz;Juergen Burg;Manfred Stolte.
Gastroenterology (2005)

274 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Markus Maeurer

Alimuddin Zumla

Alimuddin Zumla

University College London

Publications: 95

Ben J. Marais

Ben J. Marais

University of Sydney

Publications: 62

Soldano Ferrone

Soldano Ferrone

Harvard University

Publications: 56

Giovanni Battista Migliori

Giovanni Battista Migliori

Queen Mary University of London

Publications: 51

Robert J. Wilkinson

Robert J. Wilkinson

The Francis Crick Institute

Publications: 35

Stephen D. Lawn

Stephen D. Lawn

London School of Hygiene & Tropical Medicine

Publications: 32

Stefan H. E. Kaufmann

Stefan H. E. Kaufmann

Max Planck Institute for Infection Biology

Publications: 32

Theresa L. Whiteside

Theresa L. Whiteside

University of Pittsburgh

Publications: 31

Jonas F. Ludvigsson

Jonas F. Ludvigsson

Karolinska Institute

Publications: 30

Giovanni Sotgiu

Giovanni Sotgiu

University of Sassari

Publications: 30

Michael T. Lotze

Michael T. Lotze

University of Pittsburgh

Publications: 29

Margot Zöller

Margot Zöller

Heidelberg University

Publications: 27

Giorgio Parmiani

Giorgio Parmiani

University of Siena

Publications: 27

Tom H. M. Ottenhoff

Tom H. M. Ottenhoff

Leiden University Medical Center

Publications: 26

Laura E. Via

Laura E. Via

National Institutes of Health

Publications: 25

Alessandro Sette

Alessandro Sette

La Jolla Institute For Allergy & Immunology

Publications: 25

Trending Scientists

Mircea Sofonea

Mircea Sofonea

University of Perpignan

Giambattista Giacomin

Giambattista Giacomin

Université Paris Cité

Yannis Kotidis

Yannis Kotidis

Athens University of Economics and Business

Donghang Yan

Donghang Yan

Chinese Academy of Sciences

Gregory J. Robertson

Gregory J. Robertson

Environment and Climate Change Canada

Dennis E. Ohman

Dennis E. Ohman

Virginia Commonwealth University Medical Center

Jozef Deckers

Jozef Deckers

KU Leuven

Richard W. Allmendinger

Richard W. Allmendinger

Cornell University

Victoria E. Hamilton

Victoria E. Hamilton

Southwest Research Institute

William H. Patrick

William H. Patrick

Louisiana State University

Angela Panoskaltsis-Mortari

Angela Panoskaltsis-Mortari

University of Minnesota

Virginia I. Douglas

Virginia I. Douglas

McGill University

Martie P. Thompson

Martie P. Thompson

Appalachian State University

Kennon A. Lattal

Kennon A. Lattal

West Virginia University

Paul W. Dickman

Paul W. Dickman

Karolinska Institute

Miles Herkenham

Miles Herkenham

National Institutes of Health

Something went wrong. Please try again later.